With obesity numbers skyrocketing and increasing coverage in the news on new obesity drugs like Ozempic and Wegovy, the recently released AGA guideline on obesity pharmacotherapy, and the pending reintroduction of the Treat and Reduce Obesity Act (TROA), it is an incredibly timely moment to explore the state of obesity care.
Pooja Singhal, MD, Director of Women's Digestive Health at SSM Health in Oklahoma City, OK, and Janese Laster, MD, Gastroenterologist and Owner of Gut Theory Total Digestive Care in Washington, DC, come together to address the topic of obesity care in the U.S. Join this engaging discussion to learn why it's crucial for gastroenterologists (GIs) to actively advocate for expanded access to care for their patients with obesity.
Resources:
https://www.gastrojournal.org/article/S0016-5085(22)01026-5/fulltext
https://www.congress.gov/bill/117th-congress/senate-bill/596/text
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168710/
https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
Faculty:
Pooja Singhal, MD
Director, Women's Digestive Diseases
Clinical Assistant Professor
Oklahoma University Health Sciences Center
Janese Laster, MD
Gastroenterology, Nutrition, Obesity Medicine
Bariatric Endoscopist
Owner of Gut Theory Total Digestive Care
Learning objectives:
- The range of obesity treatment options available today and barriers to access.
- The role of GIs in obesity treatment and why GIs should treat and manage patients with obesity.
- Background on TROA, the status of the legislation, and the potential implications of the legislation on both patients and providers.
- How GIs can advocate to expand access to the full spectrum of obesity treatment.
Pricing
| Member | Nonmember |
|---|---|
| $Free | $Free |
Original release date: June 12, 2023
Expiration date: June 12, 2025